Navigation Links
Computer vision reduces risk in clinical trials
Date:11/19/2012

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- New York City-based Ai Cure Technologies opened the Innovation Showcase at CNS Summit in Boca Raton, Fla, with a presentation of its flagship digital health solution,  AiView™. The interactive computer-vision software makes use of the webcam on a smartphone or tablet computer to automatically monitor medication adherence in clinical trials and ongoing care settings.

(Logo: http://photos.prnewswire.com/prnh/20121119/NY16060LOGO)

Clinical trial coordinators and healthcare providers can use the technology to automatically monitor patient medication adherence in real-time. Using their smartphones or tablets, patients are alerted to take their medication and can activate the system which will confirm their identity, the medication and confirm medication ingestion. The simple process takes 15 seconds to complete. Adherence data are immediately and securely transmitted to a centralized dashboard. Nonadherence events, including missed doses or incorrect medication ingestion, trigger alerts that allow coordinators or providers to intervene immediately, using a variety of integrated communication options.

"Through our patent-pending computer vision technology, we're able to simply and inexpensively automate the process of watching a patient take their medication - otherwise known as directly observed therapy (DOT) - and extend this approach to a population level. This type of monitoring ensures that the validity of clinical trial data is not compromised by medication nonadherence," said Adam Hanina, Chairman and CEO of Ai Cure Technologies, Inc. "We've found that even patients who may be considered high-risk enjoy interacting with the system."

As the system is software-based and does not require any alteration to the medication, AiView can be quickly rolled out into a clinical trial. And unlike self-reported text messaging, the system provides visual confirmation that the medication has been correctly ingested. AiView is commercially available and is currently operational in clinical trials in North America.

AiView is HIPAA and 21 CFR Part 11 compliant.

About Ai Cure Technologies, Inc.
Ai Cure Technologies is a digital health solutions' company focused on the development of interactive and flexible computer vision technologies. These accurately and effectively monitor real-time medication adherence in clinical trials and ongoing care settings. Ai Cure Technologies has developed cost-effective and scalable solutions that combine automated computer vision technology with dynamic patient feedback, offering a new gold standard in medication adherence monitoring. The computer vision platform is currently being extended to develop a robust authentication system to combat drug counterfeiting.  

Ai Cure Technologies is the recipient of three National Institutes of Health innovation grants. For more information, visit the company's website at www.aicure.com.

About the CNS Summit
The annual CNS Summit brings together leaders in CNS drug development to collaborate so as to optimize success in CNS clinical trials and accelerate development of new treatments for patients suffering from brain disorders. Corporate Inquiries:Media contact:Gordon KesslerPress Officer Ai Cure Technologies, Inc.Ai Cure Technologies, Inc.gordon.kessler@aicure.compress@aicure.com800-570-0448800-570-0448


'/>"/>
SOURCE Ai Cure Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Stanford engineers use nanophotonics to reshape on-chip computer data transmission
2. K computer research results awarded ACM Gordon Bell Prize
3. New method for enhancing thermal conductivity could cool computer chips, lasers and other devices
4. NSF CAREER grants support ocean energy, microforming, computer planning
5. Honeycombs of magnets could lead to new type of computer processing
6. Quantum computer built inside a diamond
7. Computer-designed molecules point to new therapy for cystic fibrosis
8. New research could mean faster computers and better mobile phones
9. People with paralysis control robotic arms to reach and grasp using brain computer interface
10. Computers & Graphics incorporates Collage Authoring Environment
11. En route to a quantum computer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
(Date:6/23/2016)... FRANCISCO , June 22, 2016  Amgen (NASDAQ: ... sponsorship of the QB3@953 life sciences incubator ... human health. The shared laboratory space at QB3@953 was ... overcome a key obstacle for many early stage organizations ... part of the sponsorship, Amgen launched two "Amgen Golden ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):